Behavioral Health Business cites OHSU research in a story about the increase in private equity ownership of freestanding psychiatric facilities nationwide.

KGW-TV cites a 2021 survey of OHSU members expressing interest in commuting by water in a story about a renewed push to attract city support of a pedestrian-only ferry system that would navigate the Willamette and Columbia rivers with a stop near OHSU’s South Waterfront Campus.

Research identifies a type of chemical compound designed and synthesized at OHSU to targets parasites causing malaria instead of the mosquitoes that carry them. Michael Riscoe, Ph.D., says, “We all feel so fortunate to be working on this project because of its vast potential to save lives.”

Corvallis Advocate story covers news that Oregon State University’s College of Pharmacy will relocate its Pharm.D. program primarily to OHSU’s Portland campus in 2026, expanding a long-established partnership that will create more opportunities for students.

Maros Ferencik, M.D., Ph.D., commenting on a new analysis for TCTMD – Cardiovascular News, said the latest results further cement the important role of CT in this care pathway, adding that current U.S. guidelines already recommend using a noninvasive test first: “This study was started before that guideline, and this is of course a European study where there are still a lot of places where [patients] go directly to the cath lab.”

In an interview with Contemporary OB/GYN, Amy Valent, D.O., discusses technological advancements for managing prenatal diabetes: “We are nowhere close to the ceiling of advancements, but from a technology perspective, it's helping people not only just understand biologically what's happening to them from the continuous glucose monitoring side, but also from just the technology side of delivering insulin, we can start to fine-tune that to hopefully more mimic our natural physiology of insulin secretion.”

The Reporter article on the annual Rockin’ Hops music festival held in support of raising awareness and funding for neurofibromatosis, a genetic disorder that affects the nervous system, Larry Sherman, Ph.D., tells a group of parents and supporters who gathered for the presentation, “So let people know and talk to your legislators to know that these kind of cuts are not acceptable. If we close our labs, there is no telling how much data will be lost.”

Story highlights research from OHSU and collaborating organizations that demonstrates how a model of artificial intelligence can better predict survival from glioblastoma and what type of treatment yielded the best outcomes. Ramon Barajas Jr., M.D., says, “We suspected that patients undergoing more aggressive surgery would have positive outcomes. However, applying our model to data from a prospective study, which included other forms of treatment and patient variables, gave us a truly objective assessment of this surgical approach and its impact on survival.”

The Lund Report publishes a story on a new nanoparticle developed by OHSU researchers that makes cancer treatment safer and more effective. Michael Henderson, B.A., says the research “lays the foundation for a new kind of nanoparticle-based therapy that could improve how we approach hard-to-treat tumors.”